We constantly invest our efforts in developing cutting-edge technologies to achieve the highest quality products. Our product lines are defined by a patented Advanced Thixotropic Technology (ATT).
The thixotropy process allows a special type of cross-linked hyaluronic acid gel to be synthesized. It gives the gel property of becoming less viscous under the pressure (injecting force) and immediately returns to original viscosity when the pressure is no longer applied. This gel’s molecules are covalently bonded, meaning they remain in the tissue for longer and are more stable. The special structure of these molecules also reduces the diffusion rate of the enzyme hyaluronidase into the matrix and results in a long-lasting gel.
Thixotropy-based products guarantee considerably better results in terms of increased volume, outstanding treatment goals and enduring effects.
The selection of the best processes for obtaining stable, highly pure and injection-optimized products with an exceptional safety profile is at the heart of our expert team.
For our medical products, we use the highest-grade raw materials from reputable manufacturers. Their high purity of a non-animal origin is obtained through the bio-fermentation process to avoid any potential foreign protein reactions. Our products also contain less than 0.001% of BDDE, which allows us to state that they are BDDE-free.
Every batch of a medical product is tested by an independent laboratory for its endotoxin content (according to the Ph. Eur. LAL test) and brought to the market only when it is verified.
Since we were established, research and development activities have been a core focus in our growth. Over the past two decades, our state-of-the-art research facilities in Dummer, Germany developed a varied number of unique patents. The main priority has always been to understand the customers’ needs and make them satisfied with the products of the highest safety through permanent quality assurance.
Our commitment to innovation and excellence has earned us the trust of the most recognized plastic surgeons and dermatologists worldwide. We constantly work on developing future products and key materials to further share our knowledge and expertise with the public. Currently, we conduct in-depth examinations to achieve new methods and techniques.
Almost 30 percent of our annual turnover is solely dedicated to R&D in the field of medical devices and cosmetics. As part of an ongoing alignment to the global standards, we also maintain relationships and cooperation with research institutes worldwide.